Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;50(11):e796-e797.
doi: 10.1097/CCM.0000000000005618. Epub 2022 Oct 13.

Can Renin-Angiotensin System Inhibitors Protect Against Acute Kidney Injury in Patients With COVID-19?

Chia Siang Kow  1 , Dinesh Sangarran Ramachandram  2 , Syed Shahzad Hasan  3   4
Affiliations
Comment

Can Renin-Angiotensin System Inhibitors Protect Against Acute Kidney Injury in Patients With COVID-19?

Chia Siang Kow et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

Comment in

  • The authors reply.
    Rocheleau GLY, Lee T, Russell JA. Rocheleau GLY, et al. Crit Care Med. 2022 Nov 1;50(11):e797-e798. doi: 10.1097/CCM.0000000000005650. Epub 2022 Oct 13. Crit Care Med. 2022. PMID: 36227049 Free PMC article. No abstract available.

Comment on

  • Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.
    Rocheleau GLY, Lee T, Mohammed Y, Goodlett D, Burns K, Cheng MP, Tran K, Sweet D, Marshall J, Slutsky AS, Murthy S, Singer J, Patrick DM, Du B, Peng Z, Lee TC, Boyd JH, Walley KR, Lamontagne F, Fowler R, Winston BW, Haljan G, Vinh DC, McGeer A, Maslove D, Patrigeon SP, Mann P, Donohoe K, Hernandez G, Russell JA; for ARBs CORONA I Investigators. Rocheleau GLY, et al. Crit Care Med. 2022 Sep 1;50(9):1306-1317. doi: 10.1097/CCM.0000000000005589. Epub 2022 May 18. Crit Care Med. 2022. PMID: 35607951 Free PMC article.

References

    1. Rocheleau GLY, Lee T, Mohammed Y, et al. : Renin-angiotensin system pathway therapeutics associated with improved outcomes in males hospitalized with COVID-19. Crit Care Med 2022. May 19. [online ahead of print] - PMC - PubMed
    1. Samaan F, Carneiro de Paula E, de Lima Souza FBG, et al. : COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in São Paulo, Brazil. PLoS One 2022; 17:e0261958. - PMC - PubMed
    1. Shankar-Hari M, Vale CL, Godolphin PJ, et al. ; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group: Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: A meta-analysis. JAMA 2021; 326:499–518 - PMC - PubMed
    1. Kow CS, Hasan SS: Possible protective effect of renin-angiotensin system inhibitors in COVID-19 induced acute kidney injury. J Am Soc Nephrol 2020; 31:1917–1918 - PMC - PubMed
    1. Azinheira Nobrega Cruz N, Gonçalves de Oliveira LC, Tedesco Silva Junior H, et al. : Angiotensin-converting enzyme 2 in the pathogenesis of renal abnormalities observed in COVID-19 patients. Front Physiol 2021; 12:700220. - PMC - PubMed

MeSH terms

Substances